{"disease":{"id":"her2-positive-metastatic-gastric-cancer","name":"her2 positive metastatic gastric cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07126561","title":"Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":43,"lead_sponsor_name":"University of Chicago","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}